Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials.

Autor:	Joura EA (AUTHOR), Leodolter S (AUTHOR), Hernandez-Avila M (AUTHOR), Wheeler CM (AUTHOR), Perez G (AUTHOR), Koutsky LA (AUTHOR), Garland SM (AUTHOR), Harper DM (AUTHOR), Tang GWK (AUTHOR), Ferris DG (AUTHOR), Steben M (AUTHOR), Jones RW (AUTHOR), Bryan J (AUTHOR), Taddeo FJ (AUTHOR), Bautista OM (AUTHOR), Esser MT (AUTHOR), Sings HL (AUTHOR), Nelson M (AUTHOR), Boslego JW (AUTHOR), Sattler C (AUTHOR)
Zdroj:	Lancet. 5/19/2007, Vol. 369 Issue 9574, p1693-1702. 10p.
Databáze:	Business Source Ultimate
Externí odkaz:	Zobrazit plný text záznamu